Dataset Viewer
Auto-converted to Parquet Duplicate
Gene
string
Gene synonym
string
Ensembl
string
Gene description
string
Uniprot
string
Chromosome
string
Position
string
Protein class
string
Biological process
string
Molecular function
string
Disease involvement
string
Evidence
string
HPA evidence
string
UniProt evidence
string
NeXtProt evidence
string
RNA tissue specificity
string
RNA tissue distribution
string
RNA tissue specificity score
float64
RNA tissue specific nTPM
string
RNA single cell type specificity
string
RNA single cell type distribution
string
RNA single cell type specificity score
float64
RNA single cell type specific nTPM
string
RNA single nuclei brain specificity
string
RNA single nuclei brain distribution
string
RNA single nuclei brain specificity score
float64
RNA single nuclei brain specific nTPM
string
RNA cancer specificity
string
RNA cancer distribution
string
RNA cancer specificity score
float64
RNA cancer specific FPKM
string
RNA brain regional specificity
string
RNA brain regional distribution
string
RNA brain regional specificity score
float64
RNA brain regional specific nTPM
string
RNA blood cell specificity
string
RNA blood cell distribution
string
RNA blood cell specificity score
float64
RNA blood cell specific nTPM
string
RNA blood lineage specificity
string
RNA blood lineage distribution
string
RNA blood lineage specificity score
float64
RNA blood lineage specific nTPM
string
RNA cell line specificity
string
RNA cell line distribution
string
RNA cell line specificity score
float64
RNA cell line specific nTPM
string
RNA tissue cell type enrichment
string
RNA mouse brain regional specificity
string
RNA mouse brain regional distribution
string
RNA mouse brain regional specificity score
float64
RNA mouse brain regional specific nTPM
string
RNA pig brain regional specificity
string
RNA pig brain regional distribution
string
RNA pig brain regional specificity score
float64
RNA pig brain regional specific nTPM
string
Antibody
string
Reliability (IH)
string
Reliability (Mouse Brain)
string
Reliability (IF)
string
Subcellular location
string
Secretome location
string
Secretome function
string
CCD Protein
string
CCD Transcript
string
Blood concentration - Conc. blood IM [pg/L]
float64
Blood concentration - Conc. blood MS [pg/L]
float64
Blood expression cluster
string
Tissue expression cluster
string
Brain expression cluster
string
Cell line expression cluster
string
Single cell expression cluster
string
Interactions
float64
Subcellular main location
string
Subcellular additional location
string
Antibody RRID
string
Cancer prognostics - Bladder Urothelial Carcinoma (TCGA)
string
Cancer prognostics - Breast Invasive Carcinoma (TCGA)
string
Cancer prognostics - Breast Invasive Carcinoma (validation)
string
Cancer prognostics - Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA)
string
Cancer prognostics - Colon Adenocarcinoma (TCGA)
string
Cancer prognostics - Colon Adenocarcinoma (validation)
string
Cancer prognostics - Glioblastoma Multiforme (TCGA)
string
Cancer prognostics - Glioblastoma Multiforme (validation)
string
Cancer prognostics - Head and Neck Squamous Cell Carcinoma (TCGA)
string
Cancer prognostics - Kidney Chromophobe (TCGA)
string
Cancer prognostics - Kidney Renal Clear Cell Carcinoma (TCGA)
string
Cancer prognostics - Kidney Renal Clear Cell Carcinoma (validation)
string
Cancer prognostics - Kidney Renal Papillary Cell Carcinoma (TCGA)
string
Cancer prognostics - Liver Hepatocellular Carcinoma (TCGA)
string
Cancer prognostics - Liver Hepatocellular Carcinoma (validation)
string
Cancer prognostics - Lung Adenocarcinoma (TCGA)
string
Cancer prognostics - Lung Adenocarcinoma (validation)
string
Cancer prognostics - Lung Squamous Cell Carcinoma (TCGA)
string
Cancer prognostics - Lung Squamous Cell Carcinoma (validation)
string
Cancer prognostics - Ovary Serous Cystadenocarcinoma (TCGA)
string
Cancer prognostics - Ovary Serous Cystadenocarcinoma (validation)
string
Cancer prognostics - Pancreatic Adenocarcinoma (TCGA)
string
Cancer prognostics - Pancreatic Adenocarcinoma (validation)
string
Cancer prognostics - Prostate Adenocarcinoma (TCGA)
string
Cancer prognostics - Rectum Adenocarcinoma (TCGA)
string
Cancer prognostics - Rectum Adenocarcinoma (validation)
string
Cancer prognostics - Skin Cuteneous Melanoma (TCGA)
string
Cancer prognostics - Stomach Adenocarcinoma (TCGA)
string
Cancer prognostics - Testicular Germ Cell Tumor (TCGA)
string
Cancer prognostics - Thyroid Carcinoma (TCGA)
string
Cancer prognostics - Uterine Corpus Endometrial Carcinoma (TCGA)
string
TSPAN6
T245, TM4SF6, TSPAN-6
ENSG00000000003
Tetraspanin 6
O43657
X
100627108-100639991
Predicted membrane proteins
null
null
null
Evidence at protein level
Evidence at transcript level
Evidence at protein level
Evidence at protein level
Low tissue specificity
Detected in many
null
null
Cell type enriched
Detected in many
6
Late spermatids: 1752.2
Cell type enhanced
Detected in many
null
astrocyte: 32.6;ependymal cell: 58.3
Low cancer specificity
Detected in all
null
null
Low region specificity
Detected in all
null
null
Immune cell enhanced
Detected in some
null
naive CD4 T-cell: 2.1
Lineage enriched
Detected in single
7
T-cells: 2.1
Low cancer specificity
Detected in many
null
null
Adrenal gland - Adrenal cortex cells, Liver - Hepatocytes, Testis - Late spermatids, Thyroid gland - Thyroid glandular cells
Low region specificity
Detected in all
null
null
Low region specificity
Detected in all
null
null
HPA004109
Approved
null
Approved
Nucleoli fibrillar center,Cell Junctions,Cytosol
null
null
null
null
null
null
Cluster 43: Non-specific - Transcription & Translation
Cluster 8: Ciliated cells - Cilium organization
Cluster 3: Choroid plexus - Cilium
Cluster 53: Squamous epithelial cells - Keratinization
Cluster 36: Late spermatids - Unknown function
2
Cell Junctions, Cytosol
Nucleoli fibrillar center
HPA004109: AB_1080301
unprognostic (1.57e-1)
unprognostic (2.05e-1)
unprognostic (1.71e-1)
unprognostic (3.61e-1)
unprognostic (3.77e-2)
unprognostic (1.13e-2)
unprognostic (4.18e-2)
unprognostic (1.93e-1)
unprognostic (2.39e-4)
unprognostic (4.52e-1)
unprognostic (4.92e-6)
unprognostic (3.04e-2)
unprognostic (1.29e-2)
unprognostic (2.25e-1)
unprognostic (1.39e-2)
unprognostic (6.76e-2)
unprognostic (6.58e-3)
unprognostic (3.61e-2)
unprognostic (1.12e-1)
unprognostic (4.14e-2)
unprognostic (2.25e-1)
unprognostic (7.49e-5)
unprognostic (1.11e-1)
unprognostic (3.30e-2)
unprognostic (3.36e-3)
unprognostic (4.23e-3)
unprognostic (1.89e-2)
unprognostic (7.95e-2)
unprognostic (2.01e-1)
unprognostic (4.60e-2)
unprognostic (1.59e-1)
TNMD
BRICD4, ChM1L, myodulin, TEM, tendin
ENSG00000000005
Tenomodulin
Q9H2S6
X
100584936-100599885
Predicted membrane proteins
null
null
null
Evidence at protein level
Evidence at transcript level
Evidence at protein level
Evidence at protein level
Tissue enhanced
Detected in some
null
adipose tissue: 20.4;breast: 12.5;seminal vesicle: 25.2
Cell type enriched
Detected in some
6
Adipocytes: 72.2
Cell type enhanced
Detected in single
null
choroid plexus epithelial cell: 2.3
Low cancer specificity
Detected in some
null
null
Low region specificity
Detected in some
null
null
Not detected in immune cells
Not detected
null
null
Not detected
Not detected
null
null
Group enriched
Detected in some
5
testis cancer: 1.1;Uterine cancer: 1.3
Skeletal muscle - Fibroblasts
Low region specificity
Detected in many
null
null
Low region specificity
Detected in many
null
null
HPA034961, HPA055634
Uncertain
null
null
null
null
null
null
null
null
null
null
Cluster 7: Adipose tissue - Mixed function
Cluster 36: Choroid plexus - Mixed function
Cluster 34: Testis cancer - Unknown function
Cluster 41: Adipocytes & Endothelial cells - Mixed function
1
null
null
HPA034961: AB_10670285, HPA055634: AB_2682868
null
null
unprognostic (2.09e-1)
null
unprognostic (1.68e-1)
null
unprognostic (6.13e-3)
null
null
null
unprognostic (1.21e-3)
null
null
null
null
null
null
null
null
null
null
null
null
null
unprognostic (2.21e-3)
null
null
null
unprognostic (1.55e-1)
null
null
DPM1
CDGIE, MPDS
ENSG00000000419
Dolichyl-phosphate mannosyltransferase subunit 1, catalytic
O60762
20
50934867-50959140
Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins
null
Glycosyltransferase, Transferase
Congenital disorder of glycosylation, Congenital muscular dystrophy, Disease variant, Dystroglycanopathy
Evidence at protein level
Evidence at transcript level
Evidence at protein level
Evidence at protein level
Low tissue specificity
Detected in all
null
null
Cell type enhanced
Detected in all
null
Basal respiratory cells: 234.7;Syncytiotrophoblasts: 265.5
Low cell type specificity
Detected in all
null
null
Low cancer specificity
Detected in all
null
null
Low region specificity
Detected in all
null
null
Low immune cell specificity
Detected in all
null
null
Low lineage specificity
Detected in all
null
null
Low cancer specificity
Detected in all
null
null
Adrenal gland - Adrenal cortex cells
Low region specificity
Detected in all
null
null
Low region specificity
Detected in all
null
null
HPA051818
Approved
null
null
null
null
null
null
null
null
null
Cluster 33: Non-specific - ATP binding
Cluster 35: Non-specific - Mitochondria
Cluster 21: Non-specific - Metabolism
Cluster 62: Non-specific - Plasma proteins
Cluster 35: Respiratory epithelial cells - Unknown function
20
null
null
HPA051818: AB_2681624
unprognostic (3.18e-1)
unprognostic (1.74e-2)
unprognostic (5.36e-2)
unprognostic (1.68e-1)
unprognostic (8.80e-2)
unprognostic (1.49e-1)
unprognostic (8.45e-2)
unprognostic (7.06e-2)
unprognostic (1.03e-3)
unprognostic (1.66e-1)
unprognostic (6.27e-3)
unprognostic (8.16e-2)
unprognostic (1.76e-2)
unprognostic (6.46e-6)
unprognostic (9.90e-3)
unprognostic (7.73e-2)
unprognostic (1.72e-2)
unprognostic (1.22e-1)
unprognostic (1.91e-1)
unprognostic (8.15e-2)
unprognostic (1.26e-2)
unprognostic (1.64e-3)
unprognostic (1.57e-1)
unprognostic (5.86e-2)
unprognostic (3.10e-3)
unprognostic (7.21e-3)
unprognostic (6.73e-2)
unprognostic (4.37e-1)
unprognostic (1.73e-1)
unprognostic (2.03e-3)
unprognostic (7.59e-2)
SCYL3
PACE-1, PACE1
ENSG00000000457
SCY1 like pseudokinase 3
Q8IZE3
1
169849631-169894267
Enzymes, Predicted intracellular proteins
null
null
null
Evidence at protein level
Evidence at protein level
Evidence at protein level
Evidence at protein level
Low tissue specificity
Detected in all
null
null
Low cell type specificity
Detected in many
null
null
Low cell type specificity
Detected in all
null
null
Low cancer specificity
Detected in all
null
null
Low region specificity
Detected in all
null
null
Low immune cell specificity
Detected in all
null
null
Low lineage specificity
Detected in all
null
null
Low cancer specificity
Detected in all
null
null
Liver - Hepatocytes
Low region specificity
Detected in all
null
null
Low region specificity
Detected in all
null
null
HPA005624, HPA072383
Approved
null
Supported
Golgi apparatus,Cytosol
null
null
null
null
null
null
Cluster 5: Non-specific - Cell proliferation
Cluster 1: Liver & Kidney - Metabolism
Cluster 50: Non-specific - Nucleic acid binding
Cluster 45: Non-specific - Nuclear processes
Cluster 55: Non-specific - Transcription
23
Golgi apparatus, Cytosol
null
HPA005624: AB_1854916, HPA072383:
unprognostic (3.28e-1)
unprognostic (1.44e-1)
unprognostic (2.23e-1)
unprognostic (2.20e-2)
unprognostic (2.36e-1)
unprognostic (7.49e-2)
unprognostic (2.41e-2)
unprognostic (6.83e-2)
unprognostic (8.54e-3)
unprognostic (9.70e-3)
unprognostic (8.33e-3)
unprognostic (3.64e-2)
unprognostic (2.88e-1)
unprognostic (2.00e-1)
unprognostic (3.30e-2)
unprognostic (2.57e-1)
unprognostic (4.61e-2)
unprognostic (1.54e-1)
unprognostic (2.06e-1)
unprognostic (3.95e-1)
unprognostic (5.87e-2)
unprognostic (1.31e-1)
unprognostic (2.85e-2)
unprognostic (3.03e-1)
unprognostic (2.05e-1)
unprognostic (1.12e-1)
unprognostic (2.20e-1)
unprognostic (1.57e-1)
unprognostic (1.70e-1)
unprognostic (7.81e-2)
unprognostic (1.02e-1)
C1orf112
FLJ10706
ENSG00000000460
Chromosome 1 open reading frame 112
Q9NSG2
1
169662007-169854080
Predicted intracellular proteins
null
null
null
Evidence at protein level
Evidence at protein level
Evidence at protein level
Evidence at protein level
Tissue enhanced
Detected in many
null
parathyroid gland: 13.0
Cell type enhanced
Detected in many
null
Microglial cells: 28.6;Spermatocytes: 36.9
Low cell type specificity
Detected in all
null
null
Low cancer specificity
Detected in many
null
null
Low region specificity
Detected in all
null
null
Low immune cell specificity
Detected in many
null
null
Low lineage specificity
Detected in many
null
null
Low cancer specificity
Detected in all
null
null
Skin - Mitotic cells (Skin), Testis - Spermatocytes
Low region specificity
Detected in many
null
null
Low region specificity
Detected in all
null
null
HPA023778, HPA024451
Uncertain
null
Supported
Nucleoplasm,Nucleoli
null
null
null
null
null
null
Cluster 10: Non-specific - Membrane trafficking
Cluster 16: Non-specific - Transcription
Cluster 55: Non-specific - Transcription
Cluster 45: Non-specific - Nuclear processes
Cluster 58: Macrophages - Innate immune response
14
Nucleoplasm
Nucleoli
HPA023778: AB_1848665, HPA024451: AB_1848667
unprognostic (5.40e-3)
unprognostic (6.36e-2)
unprognostic (3.03e-2)
unprognostic (3.39e-2)
unprognostic (2.38e-3)
unprognostic (5.45e-2)
unprognostic (1.03e-1)
unprognostic (1.58e-2)
unprognostic (2.87e-2)
null
unprognostic (6.97e-4)
unprognostic (1.94e-2)
null
unprognostic (3.57e-3)
unprognostic (2.09e-2)
unprognostic (2.24e-4)
unprognostic (8.25e-5)
unprognostic (5.68e-2)
unprognostic (1.47e-1)
unprognostic (3.99e-1)
unprognostic (5.71e-1)
unprognostic (2.66e-5)
unprognostic (1.12e-2)
null
unprognostic (2.85e-1)
unprognostic (1.25e-1)
unprognostic (1.50e-1)
unprognostic (1.75e-1)
unprognostic (1.68e-1)
null
unprognostic (1.21e-2)
FGR
c-fgr, p55c-fgr, SRC2
ENSG00000000938
FGR proto-oncogene, Src family tyrosine kinase
P09769
1
27612064-27635185
Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins
Immunity, Innate immunity
Kinase, Transferase, Tyrosine-protein kinase
Proto-oncogene
Evidence at protein level
Evidence at protein level
Evidence at protein level
Evidence at protein level
Group enriched
Detected in many
6
bone marrow: 205.7;lung: 83.9;lymphoid tissue: 137.8
Cell type enhanced
Detected in many
null
Hofbauer cells: 117.4;Kupffer cells: 202.5;Langerhans cells: 79.5;Macrophages: 138.9;monocytes: 398.9;NK-cells: 135.9
Group enriched
Detected in some
12
endothelial cell: 71.5;leukocyte: 85.8
Low cancer specificity
Detected in all
null
null
Low region specificity
Detected in all
null
null
Low immune cell specificity
Detected in all
null
null
Low lineage specificity
Detected in all
null
null
Group enriched
Detected in some
16
Leukemia: 21.4;lymphoma: 33.4;Myeloma: 17.9
Adipose subcutaneous - Macrophages, Adrenal gland - Neutrophils, Heart muscle - Neutrophils, Liver - Neutrophils, Lung - Neutrophil_2, Minor Salivary Gland - Macrophages, Skin - Macrophages, Spleen - Neutrophils
Not detected
Not detected
null
null
Low region specificity
Detected in all
null
null
HPA002024
Enhanced
null
Approved
Plasma membrane,Aggresome
null
null
null
null
null
null
Cluster 37: Monocytes & Neutrophils - Innate immune response
Cluster 81: Lymphoid tissue & Bone marrow - Innate immune response
Cluster 47: Endothelial cells - Vasculature
Cluster 55: Lymphoma - Immune response
Cluster 29: Monocytes - Innate immune response
16
Plasma membrane
Aggresome
HPA002024: AB_1078503
unprognostic (2.10e-3)
unprognostic (1.20e-2)
unprognostic (1.09e-5)
unprognostic (4.05e-2)
unprognostic (2.40e-1)
unprognostic (5.05e-2)
unprognostic (9.62e-4)
unprognostic (1.29e-1)
unprognostic (7.20e-2)
unprognostic (1.04e-1)
unprognostic (1.44e-2)
unprognostic (2.77e-1)
unprognostic (5.30e-2)
unprognostic (1.35e-2)
unprognostic (2.10e-1)
unprognostic (2.85e-2)
unprognostic (2.44e-3)
unprognostic (8.28e-2)
unprognostic (4.34e-1)
unprognostic (2.14e-1)
unprognostic (9.31e-2)
unprognostic (1.89e-2)
unprognostic (5.19e-3)
unprognostic (3.82e-2)
unprognostic (5.32e-4)
unprognostic (9.76e-3)
unprognostic (1.08e-1)
unprognostic (9.64e-2)
unprognostic (5.05e-2)
unprognostic (2.29e-1)
unprognostic (9.55e-2)
CFH
ARMD4, ARMS1, FHL1, HF, HF1, HF2, HUS
ENSG00000000971
Complement factor H
P08603
1
196651754-196752476
Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins
Complement alternate pathway, Host-virus interaction, Immunity, Innate immunity
null
Age-related macular degeneration, Cancer-related genes, Disease variant, Hemolytic uremic syndrome
Evidence at protein level
Evidence at protein level
Evidence at protein level
Evidence at protein level
Tissue enriched
Detected in all
6
liver: 1645.3
Cell type enhanced
Detected in many
null
Fibroblasts: 355.9;Hepatocytes: 834.8;Leydig cells: 285.2;Mesothelial cells: 388.2;Ovarian stromal cells: 208.2
Group enriched
Detected in many
7
endothelial cell: 317.6;fibroblast: 269.5;pericyte: 401.5;vascular associated smooth muscle cell: 148.7
Cancer enriched
Detected in all
9
Liver Hepatocellular Carcinoma (TCGA): 468.2
Region enhanced
Detected in all
null
choroid plexus: 43.6
Immune cell enhanced
Detected in some
null
MAIT T-cell: 17.6
Lineage enriched
Detected in single
56
T-cells: 17.6
Cancer enhanced
Detected in many
null
Gallbladder cancer: 59.2
Adrenal gland - Fibroblasts, Heart muscle - Fibroblasts, Liver - Hepatocytes, Lung - Fibroblast_2
null
null
null
null
null
null
null
null
CAB016385, CAB016769, HPA038922, HPA049176, HPA053326
Supported
null
Approved
Vesicles
Secreted to blood
Immunity
null
null
396,000,000,000
130,000,000,000
Cluster 1: T-cells - Unknown function
Cluster 83: Liver - Metabolism
Cluster 42: Choroid plexus - Mitochondria
Cluster 71: Lymphoma - Inflammatory response
Cluster 53: Fibroblasts - ECM organization
9
Vesicles
null
CAB016385: AB_627572, CAB016769: , HPA038922: AB_2676271, HPA049176: AB_2680663, HPA053326: AB_2682113
unprognostic (3.13e-1)
unprognostic (2.15e-1)
unprognostic (4.36e-1)
unprognostic (1.11e-1)
unprognostic (3.06e-1)
unprognostic (8.76e-2)
unprognostic (2.05e-3)
unprognostic (3.31e-4)
unprognostic (2.53e-1)
unprognostic (1.00e-1)
unprognostic (3.90e-3)
unprognostic (2.61e-2)
unprognostic (1.18e-1)
unprognostic (1.61e-3)
unprognostic (3.15e-3)
unprognostic (1.59e-1)
unprognostic (1.52e-2)
unprognostic (2.07e-1)
unprognostic (2.26e-2)
unprognostic (5.66e-2)
unprognostic (2.03e-2)
unprognostic (4.27e-2)
unprognostic (1.04e-1)
unprognostic (1.81e-1)
unprognostic (6.36e-2)
unprognostic (1.33e-1)
unprognostic (1.27e-2)
unprognostic (8.56e-3)
unprognostic (8.89e-3)
unprognostic (2.24e-1)
unprognostic (2.87e-2)
FUCA2
dJ20N2.5, MGC1314
ENSG00000001036
Alpha-L-fucosidase 2
Q9BTY2
6
143494812-143511720
Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins
null
Glycosidase, Hydrolase
null
Evidence at protein level
Evidence at transcript level
Evidence at protein level
Evidence at protein level
Tissue enhanced
Detected in all
null
parathyroid gland: 159.9
Low cell type specificity
Detected in many
null
null
Low cell type specificity
Detected in all
null
null
Low cancer specificity
Detected in all
null
null
Low region specificity
Detected in all
null
null
Low immune cell specificity
Detected in all
null
null
Low lineage specificity
Detected in all
null
null
Low cancer specificity
Detected in all
null
null
Skin - Fibroblast_2, Spleen - Macrophages, Thyroid gland - Thyroid glandular cells
Low region specificity
Detected in all
null
null
Low region specificity
Detected in all
null
null
HPA031659, HPA031661
Approved
null
null
null
Secreted to blood
Enzyme
null
null
null
86,000,000
Cluster 38: Monocytes & Neutrophils - Degranulation
Cluster 24: Parathyroid gland - Vesicular transport
Cluster 50: Non-specific - Nucleic acid binding
Cluster 28: Non-specific - Nuclear processes
Cluster 77: Plasma cells - Protein processing
16
null
null
HPA031659: AB_10600661, HPA031661: AB_10601681
unprognostic (7.65e-2)
unprognostic (1.78e-3)
unprognostic (1.06e-2)
unprognostic (1.77e-2)
unprognostic (2.02e-2)
unprognostic (7.60e-3)
unprognostic (2.82e-2)
unprognostic (3.42e-4)
unprognostic (2.48e-2)
unprognostic (6.94e-3)
unprognostic (1.03e-4)
unprognostic (1.52e-1)
unprognostic (3.29e-2)
unprognostic (1.22e-10)
unprognostic (2.82e-8)
unprognostic (1.38e-5)
unprognostic (4.73e-2)
unprognostic (8.50e-2)
unprognostic (5.08e-3)
unprognostic (2.53e-3)
unprognostic (8.04e-2)
unprognostic (2.21e-1)
unprognostic (9.57e-2)
unprognostic (2.60e-1)
unprognostic (1.47e-1)
unprognostic (8.60e-3)
unprognostic (3.20e-1)
unprognostic (6.23e-2)
unprognostic (1.27e-1)
unprognostic (6.09e-2)
unprognostic (2.35e-2)
GCLC
GCS, GLCL, GLCLC
ENSG00000001084
Glutamate-cysteine ligase catalytic subunit
P48506
6
53497341-53616970
Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins
Glutathione biosynthesis
Ligase
Disease variant, Hereditary hemolytic anemia
Evidence at protein level
Evidence at protein level
Evidence at protein level
Evidence at protein level
Tissue enhanced
Detected in all
null
liver: 147.6
Low cell type specificity
Detected in many
null
null
Low cell type specificity
Detected in all
null
null
Cancer enhanced
Detected in all
null
Lung Squamous Cell Carcinoma (TCGA): 133.6
Low region specificity
Detected in all
null
null
Immune cell enhanced
Detected in many
null
NK-cell: 4.2
Low lineage specificity
Detected in many
null
null
Cancer enhanced
Detected in all
null
Gallbladder cancer: 429.9
Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Adrenal gland - Adrenal cortex cells, Liver - Hepatocytes, Spleen - Macrophages
Low region specificity
Detected in all
null
null
Low region specificity
Detected in all
null
null
CAB009569, HPA036359, HPA036360
Approved
null
Approved
Nucleoplasm,Nucleoli,Cytosol
null
null
null
null
null
6,000,000
Cluster 41: Basophils - Unknown function
Cluster 83: Liver - Metabolism
Cluster 13: Oligodendrocytes - Mixed function
Cluster 7: Liver cancer - Metabolism
Cluster 12: Squamous epithelial cells - Keratinization
7
Nucleoplasm
Nucleoli, Cytosol
CAB009569: AB_675582, HPA036359: AB_10672243, HPA036360: AB_10669789
unprognostic (1.08e-1)
unprognostic (2.34e-2)
unprognostic (6.97e-2)
unprognostic (3.56e-3)
unprognostic (1.58e-1)
unprognostic (6.77e-2)
unprognostic (1.44e-1)
unprognostic (1.15e-1)
unprognostic (1.93e-1)
unprognostic (3.34e-2)
unprognostic (6.04e-8)
unprognostic (1.31e-3)
unprognostic (3.69e-3)
unprognostic (3.95e-1)
unprognostic (1.23e-1)
unprognostic (8.70e-4)
unprognostic (5.88e-2)
unprognostic (2.42e-1)
unprognostic (6.42e-2)
unprognostic (3.83e-1)
unprognostic (1.92e-1)
unprognostic (1.85e-1)
unprognostic (8.98e-2)
unprognostic (2.18e-2)
unprognostic (9.49e-4)
unprognostic (4.34e-1)
unprognostic (2.33e-3)
unprognostic (4.10e-1)
unprognostic (1.65e-1)
unprognostic (3.69e-2)
unprognostic (2.18e-1)
NFYA
CBF-B, HAP2, NF-YA
ENSG00000001167
Nuclear transcription factor Y subunit alpha
P23511
6
41072974-41102403
Predicted intracellular proteins, Transcription factors
Biological rhythms, Transcription, Transcription regulation
Activator, DNA-binding
null
Evidence at protein level
Evidence at protein level
Evidence at protein level
Evidence at protein level
Low tissue specificity
Detected in all
null
null
Cell type enhanced
Detected in many
null
Early spermatids: 37.8;Late spermatids: 48.8
Low cell type specificity
Detected in all
null
null
Low cancer specificity
Detected in all
null
null
Low region specificity
Detected in all
null
null
Low immune cell specificity
Detected in all
null
null
Low lineage specificity
Detected in all
null
null
Low cancer specificity
Detected in all
null
null
Testis - Early spermatids
Low region specificity
Detected in all
null
null
Low region specificity
Detected in all
null
null
CAB009250, HPA050779
Enhanced
null
Supported
Nucleoplasm
null
null
null
null
null
null
Cluster 33: Non-specific - ATP binding
Cluster 40: Non-specific - Transcription
Cluster 11: White matter - Signal transduction
Cluster 28: Non-specific - Nuclear processes
Cluster 63: Late spermatids - Spermatogenesis
32
Nucleoplasm
null
CAB009250: AB_2152107, HPA050779: AB_2681234
unprognostic (8.42e-2)
unprognostic (2.79e-2)
unprognostic (2.71e-2)
unprognostic (4.04e-3)
unprognostic (4.07e-1)
unprognostic (1.42e-1)
unprognostic (4.75e-1)
unprognostic (2.37e-2)
unprognostic (3.49e-2)
unprognostic (5.15e-3)
unprognostic (5.08e-4)
unprognostic (7.41e-3)
unprognostic (3.83e-2)
unprognostic (1.68e-3)
unprognostic (1.39e-2)
unprognostic (1.83e-2)
unprognostic (7.19e-3)
unprognostic (3.32e-1)
unprognostic (8.77e-2)
unprognostic (2.18e-1)
unprognostic (1.05e-1)
unprognostic (3.61e-3)
unprognostic (1.13e-1)
unprognostic (3.23e-1)
unprognostic (9.49e-3)
unprognostic (1.59e-1)
unprognostic (3.51e-2)
unprognostic (3.57e-1)
unprognostic (1.46e-1)
unprognostic (3.53e-2)
unprognostic (6.11e-2)
STPG1
C1orf201, FLJ33340, MAPO2
ENSG00000001460
Sperm tail PG-rich repeat containing 1
Q5TH74
1
24356999-24416934
Predicted intracellular proteins
Apoptosis
null
null
Evidence at protein level
Evidence at protein level
Evidence at protein level
Evidence at protein level
Tissue enhanced
Detected in all
null
testis: 26.7
Group enriched
Detected in many
13
Early spermatids: 214.1;Late spermatids: 677.5
Cell type enhanced
Detected in all
null
ependymal cell: 101.0
Low cancer specificity
Detected in all
null
null
Low region specificity
Detected in all
null
null
Low immune cell specificity
Detected in some
null
null
Low lineage specificity
Detected in many
null
null
Low cancer specificity
Detected in all
null
null
Lung - Respiratory ciliated cells, Testis - Early spermatids, Testis - Late spermatids
Low region specificity
Detected in many
null
null
Low region specificity
Detected in many
null
null
HPA024301
null
null
Approved
Nucleoplasm
null
null
null
null
null
null
Cluster 12: Non-specific - Mitochondrial translation
Cluster 8: Ciliated cells - Cilium organization
Cluster 52: Neurons & Synapses - Synaptic function
Cluster 37: Non-specific - mRNA processing
Cluster 63: Late spermatids - Spermatogenesis
null
Nucleoplasm
null
HPA024301: AB_1845634
unprognostic (4.58e-2)
unprognostic (3.44e-1)
null
unprognostic (1.35e-1)
unprognostic (2.48e-2)
unprognostic (1.79e-1)
unprognostic (5.99e-5)
null
unprognostic (7.83e-3)
unprognostic (2.52e-2)
unprognostic (1.12e-8)
unprognostic (1.99e-2)
unprognostic (1.67e-2)
unprognostic (2.89e-3)
null
unprognostic (4.01e-3)
unprognostic (1.67e-1)
unprognostic (1.19e-2)
unprognostic (1.89e-1)
unprognostic (1.85e-1)
unprognostic (2.57e-1)
unprognostic (3.50e-1)
unprognostic (1.54e-1)
unprognostic (3.39e-2)
unprognostic (3.81e-2)
unprognostic (1.24e-1)
unprognostic (2.06e-1)
unprognostic (5.50e-2)
unprognostic (1.34e-1)
unprognostic (4.45e-1)
unprognostic (5.63e-2)
NIPAL3
DJ462O23.2, NPAL3, SLC57A5
ENSG00000001461
NIPA like domain containing 3
Q6P499
1
24415802-24472976
Predicted intracellular proteins, Predicted membrane proteins, Transporters
null
null
null
Evidence at protein level
Evidence at protein level
Evidence at protein level
Evidence at protein level
Tissue enhanced
Detected in all
null
brain: 65.3
Cell type enhanced
Detected in all
null
Cone photoreceptor cells: 98.6;Oligodendrocytes: 85.5;Prostatic glandular cells: 192.0
Low cell type specificity
Detected in all
null
null
Low cancer specificity
Detected in all
null
null
Low region specificity
Detected in all
null
null
Low immune cell specificity
Detected in all
null
null
Low lineage specificity
Detected in all
null
null
Low cancer specificity
Detected in all
null
null
Adrenal gland - Adrenal cortex cells, Colon - Smooth muscle cells, Prostate - Prostate glandular cells, Testis - Sertoli cells, Thyroid gland - Thyroid glandular cells
Low region specificity
Detected in all
null
null
Low region specificity
Detected in all
null
null
HPA039978
Approved
null
Approved
Nucleoplasm
null
null
null
null
null
null
Cluster 5: Non-specific - Cell proliferation
Cluster 9: Oligodendrocytes - Myelination
Cluster 26: Oligodendrocytes - Mixed function
Cluster 64: Connective tissue cells - ECM organization
Cluster 40: Prostatic glandular cells - Transcription
8
Nucleoplasm
null
HPA039978: AB_10697712
unprognostic (2.29e-1)
unprognostic (1.46e-1)
unprognostic (6.19e-2)
unprognostic (2.88e-3)
unprognostic (1.76e-2)
unprognostic (1.03e-1)
unprognostic (6.52e-2)
unprognostic (2.43e-2)
unprognostic (7.61e-2)
unprognostic (1.99e-2)
unprognostic (1.35e-9)
unprognostic (3.24e-3)
unprognostic (1.25e-2)
unprognostic (8.50e-5)
unprognostic (1.15e-1)
unprognostic (6.18e-2)
unprognostic (1.10e-1)
unprognostic (2.17e-1)
unprognostic (3.41e-2)
unprognostic (9.12e-2)
unprognostic (7.92e-2)
unprognostic (6.60e-2)
unprognostic (1.08e-4)
unprognostic (2.17e-1)
unprognostic (8.50e-2)
unprognostic (4.05e-2)
unprognostic (3.85e-1)
unprognostic (3.08e-2)
unprognostic (1.82e-1)
unprognostic (2.38e-2)
unprognostic (1.61e-2)
LAS1L
FLJ12525, Las1
ENSG00000001497
LAS1 like ribosome biogenesis factor
Q9Y4W2
X
65438549-65534810
Disease related genes, Human disease related genes, Predicted intracellular proteins
rRNA processing
Hydrolase
Disease variant, Intellectual disability, Obesity
Evidence at protein level
Evidence at protein level
Evidence at protein level
Evidence at protein level
Low tissue specificity
Detected in all
null
null
Cell type enhanced
Detected in all
null
Late spermatids: 143.1
Low cell type specificity
Detected in all
null
null
Low cancer specificity
Detected in all
null
null
Low region specificity
Detected in all
null
null
Low immune cell specificity
Detected in all
null
null
Low lineage specificity
Detected in all
null
null
Low cancer specificity
Detected in all
null
null
Testis - Sertoli cells
Low region specificity
Detected in all
null
null
Low region specificity
Detected in all
null
null
HPA044431, HPA061463
Supported
null
Uncertain
Nucleoplasm,Centriolar satellite,Cytosol
null
null
null
null
null
null
Cluster 13: Non-specific - Mitochondria
Cluster 66: Non-specific - Transcription
Cluster 13: Oligodendrocytes - Mixed function
Cluster 36: Non-specific - mRNA processing
Cluster 63: Late spermatids - Spermatogenesis
51
Nucleoplasm
Centriolar satellite, Cytosol
HPA044431: AB_10965695, HPA061463: AB_2684530
unprognostic (1.42e-1)
unprognostic (3.99e-3)
unprognostic (1.49e-1)
unprognostic (1.80e-3)
unprognostic (2.24e-1)
unprognostic (4.98e-2)
unprognostic (5.11e-1)
unprognostic (4.67e-3)
unprognostic (6.80e-3)
unprognostic (5.41e-2)
unprognostic (1.15e-3)
unprognostic (7.75e-2)
unprognostic (5.08e-2)
unprognostic (1.99e-2)
unprognostic (3.52e-4)
unprognostic (3.01e-2)
unprognostic (2.88e-3)
unprognostic (5.13e-2)
unprognostic (1.66e-1)
unprognostic (1.40e-1)
unprognostic (2.56e-2)
unprognostic (2.64e-2)
unprognostic (5.67e-3)
unprognostic (4.29e-2)
unprognostic (2.84e-1)
unprognostic (8.22e-2)
unprognostic (1.30e-1)
unprognostic (9.82e-2)
unprognostic (7.60e-4)
unprognostic (1.99e-2)
unprognostic (3.23e-2)
ENPP4
AP3Aase, KIAA0879, NPP4
ENSG00000001561
Ectonucleotide pyrophosphatase/phosphodiesterase 4
Q9Y6X5
6
46129989-46146688
Enzymes, Predicted membrane proteins
Blood coagulation, Hemostasis
Hydrolase
null
Evidence at protein level
Evidence at transcript level
Evidence at protein level
Evidence at protein level
Low tissue specificity
Detected in all
null
null
Cell type enhanced
Detected in many
null
Basal prostatic cells: 95.2;dendritic cells: 70.1;Oligodendrocytes: 116.7
Cell type enhanced
Detected in all
null
oligodendrocyte: 134.6
Low cancer specificity
Detected in many
null
null
Low region specificity
Detected in all
null
null
Low immune cell specificity
Detected in many
null
null
Low lineage specificity
Detected in many
null
null
Low cancer specificity
Detected in many
null
null
Breast - Endothelial cells
Low region specificity
Detected in all
null
null
Low region specificity
Detected in all
null
null
HPA016594
Approved
null
null
null
null
null
null
null
null
null
Cluster 3: Non-specific - Nuclear processes
Cluster 9: Oligodendrocytes - Myelination
Cluster 28: Oligodendrocytes - Mixed function
Cluster 15: Kidney cancer - Membrane components
Cluster 3: Basal prostatic cells - Lipid metabolism
10
null
null
HPA016594: AB_1848171
unprognostic (5.85e-3)
unprognostic (3.15e-2)
unprognostic (1.14e-1)
unprognostic (2.42e-2)
unprognostic (4.22e-2)
unprognostic (6.22e-2)
unprognostic (3.13e-1)
unprognostic (3.85e-2)
unprognostic (1.48e-1)
unprognostic (1.79e-1)
unprognostic (9.35e-9)
unprognostic (7.29e-4)
unprognostic (6.11e-2)
unprognostic (9.29e-2)
unprognostic (7.56e-2)
unprognostic (6.89e-3)
unprognostic (4.05e-2)
unprognostic (3.49e-4)
unprognostic (2.75e-2)
unprognostic (1.77e-1)
unprognostic (3.70e-3)
unprognostic (3.08e-1)
unprognostic (2.22e-2)
unprognostic (2.51e-1)
unprognostic (1.08e-1)
unprognostic (3.08e-3)
null
unprognostic (1.05e-1)
unprognostic (1.99e-1)
unprognostic (3.58e-2)
unprognostic (1.19e-1)
SEMA3F
Sema4, SEMAK
ENSG00000001617
Semaphorin 3F
Q13275
3
50155045-50189075
Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins
null
null
null
Evidence at protein level
Evidence at transcript level
Evidence at transcript level
Evidence at protein level
Tissue enhanced
Detected in all
null
esophagus: 97.9
Cell type enhanced
Detected in many
null
Adipocytes: 38.2;Basal prostatic cells: 33.1;Bipolar cells: 23.9;Endothelial cells: 26.5;Suprabasal keratinocytes: 34.7
Cell type enhanced
Detected in many
null
endothelial cell: 28.8
Low cancer specificity
Detected in all
null
null
Low region specificity
Detected in all
null
null
Not detected in immune cells
Not detected
null
null
Not detected
Not detected
null
null
Cancer enhanced
Detected in all
null
Gallbladder cancer: 84.1
Adipose visceral - Endothelial cells, Adrenal gland - Endothelial cells, Colon - Endothelial cells, Heart muscle - Endothelial cells, Kidney - Endothelial cells, Liver - Vascular Endothelial cells, Lung - Endothelial cells, Pituitary gland - Endothelial cells, Skin - Keratinocyte (other)
Low region specificity
Detected in all
null
null
Low region specificity
Detected in many
null
null
HPA035008
Approved
null
null
null
Secreted to blood
Developmental protein
null
null
1,700,000
7,000,000
null
Cluster 27: Squamous epithelium - Keratinization
Cluster 38: Sub-cortical - Mixed function
Cluster 48: Adipocytes & Endothelial cells - Angiogenesis
Cluster 12: Squamous epithelial cells - Keratinization
null
null
null
HPA035008: AB_10604091
unprognostic (5.00e-2)
unprognostic (2.59e-1)
unprognostic (1.13e-1)
unprognostic (1.75e-1)
unprognostic (1.99e-1)
unprognostic (1.33e-2)
unprognostic (2.23e-3)
unprognostic (1.99e-2)
unprognostic (2.34e-1)
unprognostic (2.50e-1)
unprognostic (8.31e-7)
unprognostic (3.53e-3)
unprognostic (2.38e-1)
unprognostic (2.74e-4)
unprognostic (9.23e-3)
unprognostic (2.30e-2)
unprognostic (7.06e-3)
unprognostic (1.45e-1)
unprognostic (2.56e-1)
unprognostic (8.53e-2)
unprognostic (2.52e-1)
unprognostic (6.67e-3)
unprognostic (2.58e-1)
unprognostic (7.71e-2)
unprognostic (3.61e-2)
unprognostic (2.36e-1)
unprognostic (1.08e-1)
unprognostic (1.26e-1)
unprognostic (1.26e-1)
unprognostic (2.20e-2)
unprognostic (1.66e-1)
CFTR
ABC35, ABCC7, CF, CFTR/MRP, dJ760C5.1, MRP7, TNR-CFTR
ENSG00000001626
CF transmembrane conductance regulator
P13569
7
117287120-117715971
Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters
Ion transport, Transport
Chloride channel, Ion channel, Isomerase
Cancer-related genes, Disease variant, FDA approved drug targets
Evidence at protein level
Evidence at protein level
Evidence at protein level
Evidence at protein level
Tissue enhanced
Detected in many
null
gallbladder: 48.4;intestine: 43.6;pancreas: 192.0
Group enriched
Detected in many
4
Ductal cells: 590.0;Late spermatids: 149.9
Cell type enhanced
Detected in many
null
oligodendrocyte: 247.2
Group enriched
Detected in many
4
Colon Adenocarcinoma (TCGA): 35.0;Kidney Chromophobe (TCGA): 72.6;Pancreatic Adenocarcinoma (TCGA): 35.8;Rectum Adenocarcinoma (TCGA): 36.5
Low region specificity
Detected in many
null
null
Not detected in immune cells
Not detected
null
null
Not detected
Not detected
null
null
Cancer enhanced
Detected in many
null
colorectal cancer: 24.2;Gastric cancer: 9.6
Adipose visceral - Mesothelial cells, Breast - Breast glandular cells, Colon - Colon enterocytes, Lung - Alveolar cells type 2, Minor Salivary Gland - Minor salivary glandular cells, Skin - Eccrine sweat gland cells
Low region specificity
Detected in single
null
null
Low region specificity
Detected in all
null
null
CAB001951, HPA021939, HPA079652
Enhanced
null
null
null
null
null
null
null
null
null
null
Cluster 15: Pancreas - Proteolysis
Cluster 11: White matter - Signal transduction
Cluster 57: Stomach & Colon cancer - Digestion
Cluster 45: Non-specific - Mixed function
372
null
null
CAB001951: , HPA021939: AB_1846578, HPA079652:
null
null
unprognostic (2.40e-1)
unprognostic (2.21e-1)
unprognostic (1.25e-2)
unprognostic (2.36e-4)
null
null
null
unprognostic (5.50e-3)
unprognostic (7.23e-3)
null
unprognostic (6.53e-2)
unprognostic (5.71e-2)
unprognostic (5.84e-2)
unprognostic (3.02e-4)
unprognostic (4.86e-1)
unprognostic (3.43e-2)
unprognostic (1.93e-1)
unprognostic (1.97e-1)
unprognostic (2.56e-2)
unprognostic (2.29e-2)
unprognostic (7.79e-2)
unprognostic (6.28e-2)
unprognostic (5.19e-3)
unprognostic (2.45e-1)
null
unprognostic (1.32e-1)
unprognostic (2.58e-1)
null
unprognostic (1.67e-3)
ANKIB1
DKFZP434A0225, KIAA1386
ENSG00000001629
Ankyrin repeat and IBR domain containing 1
Q9P2G1
7
92245974-92401383
Enzymes, Predicted intracellular proteins
Ubl conjugation pathway
Transferase
null
Evidence at protein level
Evidence at protein level
Evidence at protein level
Evidence at protein level
Low tissue specificity
Detected in all
null
null
Cell type enhanced
Detected in all
null
Excitatory neurons: 176.4;Inhibitory neurons: 209.0;Oligodendrocyte precursor cells: 165.6;Oligodendrocytes: 549.9
Low cell type specificity
Detected in all
null
null
Low cancer specificity
Detected in all
null
null
Low region specificity
Detected in all
null
null
Low immune cell specificity
Detected in many
null
null
Low lineage specificity
Detected in many
null
null
Low cancer specificity
Detected in all
null
null
Adrenal gland - Adrenal cortex cells, Testis - Spermatocytes
Low region specificity
Detected in all
null
null
Low region specificity
Detected in all
null
null
HPA019358, HPA021780
Uncertain
null
Supported
Plasma membrane,Cytosol
null
null
null
null
null
null
Cluster 14: Non-specific - Unknown function
Cluster 61: Brain - Neuronal signaling
Cluster 13: Oligodendrocytes - Mixed function
Cluster 39: Non-specific - Transcription
Cluster 51: Oligodendrocytes - Unknown function
2
Plasma membrane, Cytosol
null
HPA019358: AB_1844831, HPA021780: AB_2670819
unprognostic (3.63e-2)
unprognostic (3.94e-2)
unprognostic (1.28e-1)
unprognostic (2.05e-3)
unprognostic (4.01e-1)
unprognostic (2.57e-1)
unprognostic (3.65e-1)
unprognostic (1.54e-1)
unprognostic (1.26e-1)
unprognostic (2.96e-6)
unprognostic (3.92e-6)
unprognostic (1.29e-1)
unprognostic (6.10e-2)
unprognostic (1.60e-4)
unprognostic (6.43e-2)
unprognostic (3.18e-2)
unprognostic (4.19e-2)
unprognostic (5.18e-2)
unprognostic (3.94e-1)
unprognostic (1.52e-1)
unprognostic (1.94e-2)
unprognostic (1.11e-3)
unprognostic (7.77e-2)
unprognostic (4.40e-2)
unprognostic (5.97e-3)
unprognostic (1.31e-1)
unprognostic (1.14e-1)
unprognostic (6.26e-3)
unprognostic (2.89e-1)
unprognostic (4.55e-2)
unprognostic (1.67e-1)
CYP51A1
CP51, CYP51, CYPL1, LDM, P450-14DM, P450L1
ENSG00000001630
Cytochrome P450 family 51 subfamily A member 1
Q16850
7
92084987-92134803
Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins
Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism
Monooxygenase, Oxidoreductase
FDA approved drug targets
Evidence at protein level
Evidence at transcript level
Evidence at protein level
Evidence at protein level
Tissue enhanced
Detected in all
null
liver: 196.0
Cell type enhanced
Detected in many
null
Early spermatids: 52.6;Kupffer cells: 56.0;Oligodendrocytes: 49.4;Squamous epithelial cells: 50.2
Low cell type specificity
Detected in all
null
null
Low cancer specificity
Detected in all
null
null
Low region specificity
Detected in all
null
null
Low immune cell specificity
Detected in all
null
null
Low lineage specificity
Detected in all
null
null
Low cancer specificity
Detected in all
null
null
Colon - Macrophages, Liver - Hepatocytes, Lung - Alveolar cells type 2, Testis - Early spermatids, Testis - Late spermatids
Low region specificity
Detected in all
null
null
Low region specificity
Detected in all
null
null
HPA041325, HPA043508
Approved
null
Approved
Endoplasmic reticulum
null
null
null
null
null
null
Cluster 13: Non-specific - Mitochondria
Cluster 69: Liver - Oxidoreductase activity
Cluster 49: Hindbrain - Mixed function
Cluster 57: Stomach & Colon cancer - Digestion
Cluster 62: Hepatocytes - Metabolism
12
Endoplasmic reticulum
null
HPA041325: AB_2677411, HPA043508: AB_2678520
unprognostic (2.56e-2)
unprognostic (1.94e-1)
unprognostic (9.05e-2)
unprognostic (2.32e-4)
unprognostic (2.91e-3)
unprognostic (1.54e-1)
unprognostic (1.62e-1)
unprognostic (1.64e-3)
unprognostic (7.22e-4)
unprognostic (7.26e-4)
unprognostic (2.27e-9)
unprognostic (6.45e-2)
unprognostic (3.14e-1)
unprognostic (1.25e-1)
unprognostic (6.25e-2)
unprognostic (3.93e-2)
unprognostic (2.40e-1)
unprognostic (2.27e-1)
unprognostic (2.67e-2)
unprognostic (3.09e-1)
unprognostic (2.54e-1)
unprognostic (1.12e-1)
unprognostic (5.56e-2)
unprognostic (3.83e-2)
unprognostic (6.86e-2)
unprognostic (1.05e-1)
unprognostic (1.49e-1)
unprognostic (1.14e-1)
unprognostic (3.85e-1)
unprognostic (4.24e-2)
unprognostic (4.72e-2)
KRIT1
CAM, CCM1
ENSG00000001631
KRIT1 ankyrin repeat containing
O00522
7
92197498-92246166
Disease related genes, Human disease related genes, Predicted intracellular proteins
Angiogenesis
null
Disease variant
Evidence at protein level
Evidence at protein level
Evidence at protein level
Evidence at protein level
Low tissue specificity
Detected in all
null
null
Cell type enhanced
Detected in all
null
Inhibitory neurons: 88.8;Oligodendrocytes: 107.4
Low cell type specificity
Detected in many
null
null
Low cancer specificity
Detected in all
null
null
Low region specificity
Detected in all
null
null
Low immune cell specificity
Detected in all
null
null
Low lineage specificity
Detected in all
null
null
Low cancer specificity
Detected in all
null
null
Testis - Spermatocytes
Low region specificity
Detected in all
null
null
Low region specificity
Detected in all
null
null
HPA049606
Supported
null
Uncertain
Vesicles
null
null
null
null
null
null
Cluster 5: Non-specific - Cell proliferation
Cluster 51: Thyroid gland - Unknown function
Cluster 55: Non-specific - Transcription
Cluster 39: Non-specific - Transcription
Cluster 49: Non-specific - Transcription
13
Vesicles
null
HPA049606: AB_2680832
unprognostic (1.91e-1)
unprognostic (1.03e-1)
unprognostic (1.72e-2)
unprognostic (3.65e-2)
unprognostic (4.37e-2)
unprognostic (2.32e-2)
unprognostic (4.30e-1)
unprognostic (9.86e-3)
unprognostic (3.80e-2)
unprognostic (4.13e-4)
unprognostic (1.96e-6)
unprognostic (2.28e-3)
unprognostic (1.81e-1)
unprognostic (3.74e-3)
unprognostic (2.24e-1)
unprognostic (3.02e-1)
unprognostic (2.04e-1)
unprognostic (2.52e-2)
unprognostic (1.39e-1)
unprognostic (3.11e-2)
unprognostic (1.19e-1)
unprognostic (1.07e-1)
unprognostic (2.89e-1)
unprognostic (1.21e-1)
unprognostic (1.01e-2)
unprognostic (1.77e-1)
unprognostic (9.49e-2)
unprognostic (7.34e-2)
unprognostic (3.28e-1)
unprognostic (5.63e-2)
unprognostic (1.67e-1)
RAD52
null
ENSG00000002016
RAD52 homolog, DNA repair protein
P43351
12
911736-990053
Cancer-related genes, Predicted intracellular proteins
DNA damage, DNA recombination, DNA repair
DNA-binding
Cancer-related genes
Evidence at protein level
Evidence at protein level
Evidence at protein level
Evidence at protein level
Low tissue specificity
Detected in all
null
null
Group enriched
Detected in many
4
Astrocytes: 33.1;Excitatory neurons: 36.7;Inhibitory neurons: 46.8;Microglial cells: 22.4;Oligodendrocyte precursor cells: 28.3;Oligodendrocytes: 50.8
Low cell type specificity
Detected in all
null
null
Low cancer specificity
Detected in all
null
null
Low region specificity
Detected in all
null
null
Low immune cell specificity
Detected in all
null
null
Low lineage specificity
Detected in all
null
null
Low cancer specificity
Detected in all
null
null
null
Low region specificity
Detected in all
null
null
Low region specificity
Detected in all
null
null
HPA028957
null
null
Approved
Nuclear speckles,Plasma membrane
null
null
null
null
null
null
Cluster 5: Non-specific - Cell proliferation
Cluster 19: Non-specific - Basic cellular processes
Cluster 11: White matter - Signal transduction
Cluster 38: Non-specific - Transcription
Cluster 8: Neurons - Neuronal signaling
23
Nuclear speckles
Plasma membrane
HPA028957: AB_2672842
unprognostic (1.35e-1)
unprognostic (5.29e-2)
unprognostic (3.23e-1)
unprognostic (1.72e-2)
unprognostic (1.69e-1)
unprognostic (1.18e-1)
unprognostic (4.94e-2)
unprognostic (9.70e-3)
unprognostic (1.75e-1)
unprognostic (6.18e-5)
unprognostic (3.05e-3)
unprognostic (3.09e-2)
unprognostic (2.70e-1)
unprognostic (2.01e-3)
unprognostic (3.94e-2)
unprognostic (1.39e-1)
unprognostic (7.56e-2)
unprognostic (2.53e-2)
unprognostic (1.27e-1)
unprognostic (1.01e-1)
unprognostic (6.98e-2)
unprognostic (4.41e-3)
unprognostic (1.81e-2)
unprognostic (3.51e-1)
unprognostic (9.94e-4)
unprognostic (3.91e-1)
unprognostic (1.00e-1)
unprognostic (5.35e-2)
unprognostic (5.06e-1)
unprognostic (8.91e-2)
unprognostic (1.89e-1)
BAD
BBC2, BCL2L8
ENSG00000002330
BCL2 associated agonist of cell death
Q92934
11
64269830-64284704
Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins
Apoptosis
null
Cancer-related genes
Evidence at protein level
Evidence at protein level
Evidence at protein level
Evidence at protein level
Low tissue specificity
Detected in all
null
null
Low cell type specificity
Detected in all
null
null
Low cell type specificity
Detected in all
null
null
Low cancer specificity
Detected in all
null
null
Low region specificity
Detected in all
null
null
Low immune cell specificity
Detected in all
null
null
Low lineage specificity
Detected in all
null
null
Low cancer specificity
Detected in all
null
null
null
Low region specificity
Detected in all
null
null
Low region specificity
Detected in all
null
null
CAB004205, HPA028185, HPA062105
Approved
null
Enhanced
Mitochondria,Mid piece,Principal piece,End piece
null
null
null
null
null
null
Cluster 29: Non-specific - Unknown function
Cluster 43: Non-specific - Mitochondrial translation
Cluster 27: Non-specific - Mixed function
Cluster 24: Non-specific - Unknown function
Cluster 5: Enterocytes - Absorption
44
Mitochondria
Mid piece, Principal piece, End piece
CAB004205: AB_626717, HPA028185: AB_10603445, HPA062105: AB_2684684
unprognostic (1.86e-1)
unprognostic (2.17e-1)
unprognostic (9.12e-3)
unprognostic (7.87e-2)
unprognostic (6.68e-2)
unprognostic (2.76e-1)
unprognostic (1.27e-1)
unprognostic (8.77e-2)
unprognostic (7.89e-2)
unprognostic (1.08e-2)
unprognostic (1.11e-1)
unprognostic (1.18e-2)
unprognostic (3.69e-2)
unprognostic (4.49e-4)
unprognostic (1.65e-1)
unprognostic (4.51e-2)
unprognostic (1.06e-1)
unprognostic (4.44e-2)
unprognostic (4.74e-1)
unprognostic (1.95e-1)
unprognostic (2.37e-1)
unprognostic (1.42e-1)
unprognostic (4.78e-4)
unprognostic (1.24e-1)
unprognostic (2.52e-1)
unprognostic (3.25e-1)
unprognostic (7.57e-2)
unprognostic (1.45e-1)
unprognostic (1.13e-1)
unprognostic (2.27e-1)
unprognostic (3.05e-1)
LAP3
LAP, LAPEP, PEPS
ENSG00000002549
Leucine aminopeptidase 3
P28838
4
17577198-17607972
Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
null
Aminopeptidase, Hydrolase, Protease
null
Evidence at protein level
Evidence at protein level
Evidence at protein level
Evidence at protein level
Low tissue specificity
Detected in all
null
null
Cell type enhanced
Detected in all
null
Hofbauer cells: 264.8;Proximal tubular cells: 263.7
Cell type enhanced
Detected in all
null
endothelial cell: 82.6
Low cancer specificity
Detected in all
null
null
Low region specificity
Detected in all
null
null
Low immune cell specificity
Detected in all
null
null
Low lineage specificity
Detected in all
null
null
Low cancer specificity
Detected in all
null
null
null
Low region specificity
Detected in all
null
null
Low region specificity
Detected in all
null
null
HPA029606, HPA029607
Enhanced
null
Approved
Nucleoplasm,Midbody,Cytosol,Calyx,Mid piece,Principal piece
null
null
Yes
No
null
5,000,000
Cluster 10: Non-specific - Membrane trafficking
Cluster 70: Lymphoid tissue - Immune response
Cluster 19: Astrocytes - Mixed function
Cluster 31: Non-specific - Antiviral immune response
Cluster 41: Adipocytes & Endothelial cells - Mixed function
15
Cytosol
Nucleoplasm, Midbody, Calyx, Mid piece, Principal piece
HPA029606: AB_10599288, HPA029607: AB_10611381
unprognostic (6.83e-2)
unprognostic (3.01e-1)
unprognostic (1.42e-2)
unprognostic (8.58e-2)
unprognostic (3.35e-2)
unprognostic (1.19e-1)
unprognostic (7.13e-2)
unprognostic (2.42e-1)
unprognostic (3.03e-1)
unprognostic (2.79e-1)
unprognostic (6.48e-5)
unprognostic (2.87e-2)
unprognostic (1.31e-2)
unprognostic (7.91e-2)
unprognostic (8.29e-2)
unprognostic (5.58e-2)
unprognostic (3.31e-2)
unprognostic (1.04e-2)
unprognostic (3.46e-1)
unprognostic (1.11e-1)
unprognostic (4.17e-2)
unprognostic (1.08e-2)
unprognostic (1.24e-1)
unprognostic (2.11e-1)
unprognostic (8.87e-2)
unprognostic (5.10e-2)
unprognostic (4.00e-2)
unprognostic (9.97e-2)
unprognostic (5.68e-3)
unprognostic (3.55e-1)
unprognostic (4.35e-1)
CD99
MIC2
ENSG00000002586
CD99 molecule (Xg blood group)
P14209
X
2691187-2741309
CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins
Cell adhesion
null
null
Evidence at protein level
Evidence at protein level
Evidence at protein level
Evidence at protein level
Low tissue specificity
Detected in all
null
null
Low cell type specificity
Detected in many
null
null
Cell type enhanced
Detected in some
null
ependymal cell: 6.5;leukocyte: 5.7;pericyte: 7.7
Low cancer specificity
Detected in all
null
null
Low region specificity
Detected in all
null
null
Low immune cell specificity
Detected in all
null
null
Low lineage specificity
Detected in all
null
null
Low cancer specificity
Detected in all
null
null
Skin - Fibroblast_1, Skin - Fibroblast_2
null
null
null
null
Low region specificity
Detected in all
null
null
CAB000020, HPA035304
Supported
null
Approved
Golgi apparatus
null
null
null
null
null
64,000,000
Cluster 13: Non-specific - Mitochondria
Cluster 41: Smooth muscle tissue - ECM organization
Cluster 39: Astrocytes - Mixed function
Cluster 12: Bone cancer - Neuronal signaling
Cluster 53: Fibroblasts - ECM organization
3
Golgi apparatus
null
CAB000020: AB_2076419, HPA035304: AB_10672861
unprognostic (3.46e-1)
unprognostic (1.46e-2)
unprognostic (3.51e-2)
unprognostic (1.62e-1)
unprognostic (2.98e-2)
unprognostic (3.47e-2)
unprognostic (3.56e-2)
null
unprognostic (5.61e-2)
unprognostic (4.04e-2)
unprognostic (6.99e-2)
unprognostic (2.45e-1)
unprognostic (8.18e-2)
unprognostic (2.31e-3)
null
unprognostic (1.13e-4)
unprognostic (2.06e-4)
unprognostic (1.39e-1)
unprognostic (3.68e-2)
unprognostic (4.27e-1)
unprognostic (2.23e-1)
unprognostic (4.12e-2)
unprognostic (4.41e-3)
unprognostic (1.69e-1)
unprognostic (2.22e-1)
unprognostic (4.33e-2)
unprognostic (3.05e-2)
unprognostic (7.86e-3)
unprognostic (7.75e-2)
unprognostic (1.30e-2)
unprognostic (5.70e-2)
HS3ST1
3OST1
ENSG00000002587
Heparan sulfate-glucosamine 3-sulfotransferase 1
O14792
4
11393150-11429564
Enzymes, Metabolic proteins, Predicted intracellular proteins
null
Transferase
null
Evidence at protein level
Evidence at transcript level
Evidence at protein level
Evidence at protein level
Tissue enhanced
Detected in many
null
ovary: 30.9
Cell type enhanced
Detected in many
null
Granulosa cells: 147.6;Ionocytes: 127.4;Lymphatic endothelial cells: 98.3;Ovarian stromal cells: 172.3;Peritubular cells: 88.0
Cell type enhanced
Detected in many
null
upper rhombic lip: 122.7
Low cancer specificity
Detected in many
null
null
Low region specificity
Detected in all
null
null
Group enriched
Detected in some
36
memory B-cell: 15.0;naive B-cell: 26.7;plasmacytoid DC: 42.5
Group enriched
Detected in many
110
B-cells: 26.7;dendritic cells: 42.5
Cancer enhanced
Detected in many
null
pancreatic cancer: 29.8
Prostate - Endothelial cells
Low region specificity
Detected in all
null
null
Low region specificity
Detected in all
null
null
HPA002237
Approved
null
Approved
Vesicles
Intracellular and membrane
Enzyme
null
null
null
null
Cluster 8: Plasmacytoid DCs - Unknown function
Cluster 64: Neuronal - Transcription
Cluster 35: Non-specific - DNA binding
Cluster 53: Squamous epithelial cells - Keratinization
Cluster 6: Ovarian stromal cells - Transcription
28
Vesicles
null
HPA002237: AB_1079085
unprognostic (1.63e-2)
unprognostic (1.88e-2)
unprognostic (7.69e-2)
unprognostic (1.77e-2)
unprognostic (3.47e-2)
unprognostic (2.20e-1)
unprognostic (1.05e-1)
unprognostic (2.44e-2)
unprognostic (1.47e-2)
unprognostic (1.52e-1)
unprognostic (6.69e-7)
unprognostic (2.72e-1)
unprognostic (6.60e-2)
null
unprognostic (6.06e-2)
unprognostic (1.78e-1)
unprognostic (4.93e-2)
unprognostic (8.28e-2)
unprognostic (2.75e-1)
unprognostic (3.49e-2)
unprognostic (5.31e-2)
unprognostic (3.83e-2)
unprognostic (2.37e-1)
unprognostic (6.00e-2)
unprognostic (4.33e-2)
unprognostic (7.61e-2)
unprognostic (1.90e-2)
unprognostic (1.62e-2)
unprognostic (1.86e-1)
unprognostic (7.93e-2)
unprognostic (1.00e-1)
AOC1
ABP, ABP1, DAO
ENSG00000002726
Amine oxidase copper containing 1
P19801
7
150824627-150861504
Enzymes, Metabolic proteins, Predicted secreted proteins
null
Heparin-binding, Oxidoreductase
null
Evidence at protein level
Evidence at protein level
Evidence at protein level
Evidence at protein level
Group enriched
Detected in many
16
intestine: 221.1;kidney: 131.7;placenta: 479.6
Cell type enhanced
Detected in many
null
Collecting duct cells: 241.2;Distal enterocytes: 377.7;Intestinal goblet cells: 116.8;Paneth cells: 304.1;Proximal enterocytes: 876.3
Group enriched
Detected in some
4
ependymal cell: 3.5;midbrain-derived inhibitory: 2.6
Cancer enhanced
Detected in many
null
Kidney Renal Clear Cell Carcinoma (TCGA): 141.2
Low region specificity
Detected in all
null
null
Immune cell enriched
Detected in some
12
eosinophil: 31.3
Lineage enriched
Detected in many
22
granulocytes: 31.3
Cancer enhanced
Detected in many
null
colorectal cancer: 48.4
Colon - Colon enterocytes
Not detected
Not detected
null
null
Not detected
Not detected
null
null
HPA031032, HPA031033
Approved
null
null
null
Secreted in other tissues
Enzyme
null
null
null
33,000,000
Cluster 36: Eosinophils - Protein ubiquitination
Cluster 45: Intestine - Digestion
Cluster 46: Brainstem - Mixed function
Cluster 57: Stomach & Colon cancer - Digestion
Cluster 5: Enterocytes - Absorption
8
null
null
HPA031032: AB_10670150, HPA031033: AB_10669670
unprognostic (2.72e-2)
unprognostic (2.10e-2)
null
unprognostic (7.24e-2)
unprognostic (1.10e-2)
unprognostic (1.33e-1)
null
null
unprognostic (3.32e-2)
unprognostic (6.01e-2)
unprognostic (1.36e-6)
unprognostic (1.03e-3)
unprognostic (1.03e-2)
unprognostic (4.78e-3)
null
unprognostic (1.06e-1)
unprognostic (2.23e-1)
unprognostic (2.76e-3)
unprognostic (1.00e-1)
unprognostic (2.30e-1)
unprognostic (2.66e-2)
unprognostic (1.10e-1)
unprognostic (4.03e-3)
unprognostic (7.64e-3)
unprognostic (3.12e-2)
unprognostic (5.26e-3)
null
unprognostic (9.01e-2)
unprognostic (2.71e-2)
unprognostic (2.02e-1)
unprognostic (1.01e-3)
WNT16
null
ENSG00000002745
Wnt family member 16
Q9UBV4
7
121325367-121341104
Predicted intracellular proteins, Predicted secreted proteins
Wnt signaling pathway
Developmental protein
null
Evidence at protein level
Evidence at transcript level
Evidence at transcript level
Evidence at protein level
Group enriched
Detected in some
4
cervix: 5.8;skin 1: 20.0
Cell type enhanced
Detected in some
null
B-cells: 3.8;Basal keratinocytes: 6.0;Endometrial stromal cells: 3.3;Inhibitory neurons: 5.8;Microglial cells: 3.6;Suprabasal keratinocytes: 6.3
Group enriched
Detected in some
4
ependymal cell: 9.1;fibroblast: 18.1;LAMP5-LHX6 and Chandelier: 9.4;MGE interneuron: 23.1
Low cancer specificity
Detected in some
null
null
Low region specificity
Detected in many
null
null
Group enriched
Detected in some
145
memory B-cell: 15.6;naive B-cell: 15.5
Lineage enriched
Detected in single
146
B-cells: 15.6
Cancer enhanced
Detected in many
null
Leukemia: 9.8
Colon - Enteric glia cells, Spleen - B-cells (Spleen)
Low region specificity
Detected in single
null
null
Low region specificity
Detected in all
null
null
null
null
null
null
null
Secreted to extracellular matrix
Developmental protein
null
null
null
null
Cluster 23: B-cells - Immunoglobulins
Cluster 13: Skin - Cornification
Cluster 23: Choroid plexus - Mixed function
Cluster 6: Leukemia - Signal transduction
Cluster 8: Neurons - Neuronal signaling
null
null
null
null
null
null
unprognostic (8.22e-2)
null
null
null
unprognostic (1.42e-3)
null
null
null
null
null
null
null
null
unprognostic (5.54e-3)
null
unprognostic (3.03e-1)
null
null
null
null
null
null
null
null
null
null
null
null
null
HECW1
KIAA0322, NEDL1
ENSG00000002746
HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1
Q76N89
7
43112629-43566001
Enzymes, Metabolic proteins, Predicted intracellular proteins
Ubl conjugation pathway
Transferase
null
Evidence at protein level
Evidence at transcript level
Evidence at protein level
Evidence at protein level
Tissue enhanced
Detected in some
null
brain: 8.0;kidney: 7.5
Cell type enhanced
Detected in some
null
Early spermatids: 131.2;Excitatory neurons: 515.5;Inhibitory neurons: 151.1;Late spermatids: 78.2;Oligodendrocyte precursor cells: 260.8
Low cell type specificity
Detected in all
null
null
Low cancer specificity
Detected in many
null
null
Low region specificity
Detected in all
null
null
Low immune cell specificity
Detected in some
null
null
Low lineage specificity
Detected in single
null
null
Low cancer specificity
Detected in many
null
null
Breast - Fibroblasts, Kidney - Proximal tubular cells, Testis - Early spermatids, Testis - Late spermatids
Low region specificity
Detected in all
null
null
Low region specificity
Detected in all
null
null
HPA007203, HPA007593, HPA007609
Uncertain
null
Approved
Nucleoli fibrillar center,Cytosol
null
null
null
null
null
null
Cluster 20: Non-specific - DNA binding
Cluster 61: Brain - Neuronal signaling
Cluster 14: Neurons - Synaptic function
Cluster 7: Liver cancer - Metabolism
Cluster 34: Neurons - Neuronal signaling
6
Nucleoli fibrillar center
Cytosol
HPA007203: AB_2667776, HPA007593: AB_1852305, HPA007609: AB_2117518
unprognostic (8.99e-2)
null
unprognostic (2.98e-1)
unprognostic (6.83e-4)
unprognostic (1.19e-3)
unprognostic (3.57e-2)
unprognostic (2.50e-1)
null
unprognostic (1.61e-1)
null
unprognostic (2.77e-3)
null
unprognostic (3.26e-2)
null
null
unprognostic (1.26e-1)
null
unprognostic (2.83e-1)
null
null
null
unprognostic (5.45e-2)
unprognostic (7.64e-2)
unprognostic (2.72e-1)
null
unprognostic (2.24e-2)
null
unprognostic (1.66e-1)
unprognostic (3.31e-1)
null
unprognostic (1.97e-2)
MAD1L1
HsMAD1, MAD1, PIG9, TP53I9, TXBP181
ENSG00000002822
Mitotic arrest deficient 1 like 1
Q9Y6D9
7
1815793-2233243
Disease related genes, Human disease related genes, Predicted intracellular proteins
Cell cycle, Cell division, Mitosis
null
Disease variant
Evidence at protein level
Evidence at protein level
Evidence at protein level
Evidence at protein level
Low tissue specificity
Detected in all
null
null
Cell type enhanced
Detected in many
null
Early spermatids: 28.1;Excitatory neurons: 20.2;Inhibitory neurons: 23.3;Late spermatids: 59.1;Microglial cells: 20.6;Oligodendrocytes: 30.2
Low cell type specificity
Detected in all
null
null
Cancer enhanced
Detected in all
null
Skin Cuteneous Melanoma (TCGA): 93.8
Low region specificity
Detected in all
null
null
Low immune cell specificity
Detected in all
null
null
Low lineage specificity
Detected in all
null
null
Low cancer specificity
Detected in all
null
null
Testis - Early spermatids, Testis - Late spermatids
Low region specificity
Detected in all
null
null
Low region specificity
Detected in all
null
null
HPA003635, CAB015338
Supported
null
Supported
Nucleoplasm,Nuclear membrane
null
null
null
null
null
null
Cluster 9: T-regs - Cell cycle regulation
Cluster 70: Lymphoid tissue - Immune response
Cluster 11: White matter - Signal transduction
Cluster 67: Non-specific - Unknown function
Cluster 7: T-cells - T-cell receptor
61
Nucleoplasm, Nuclear membrane
null
CAB015338: AB_627901, HPA003635: AB_1853472
unprognostic (1.28e-1)
unprognostic (1.64e-1)
unprognostic (2.37e-1)
unprognostic (3.34e-1)
unprognostic (1.85e-2)
unprognostic (7.03e-2)
unprognostic (1.08e-1)
unprognostic (1.97e-2)
unprognostic (5.34e-2)
unprognostic (1.44e-1)
unprognostic (3.78e-2)
unprognostic (1.01e-1)
unprognostic (8.39e-4)
unprognostic (1.86e-4)
unprognostic (3.70e-2)
unprognostic (2.46e-2)
unprognostic (4.94e-2)
unprognostic (9.24e-2)
unprognostic (1.46e-1)
unprognostic (2.21e-3)
unprognostic (1.05e-1)
unprognostic (1.61e-1)
unprognostic (5.09e-4)
unprognostic (7.47e-2)
unprognostic (1.61e-1)
unprognostic (6.41e-2)
unprognostic (3.20e-2)
unprognostic (2.03e-1)
unprognostic (2.36e-2)
unprognostic (1.14e-1)
unprognostic (3.76e-1)
LASP1
Lasp-1, MLN50
ENSG00000002834
LIM and SH3 protein 1
Q14847
17
38869859-38921770
Cancer-related genes, Plasma proteins, Predicted intracellular proteins
Ion transport, Transport
Actin-binding
Cancer-related genes
Evidence at protein level
Evidence at protein level
Evidence at protein level
Evidence at protein level
Low tissue specificity
Detected in all
null
null
Cell type enhanced
Detected in all
null
Late spermatids: 588.6;Proximal enterocytes: 277.0
Low cell type specificity
Detected in all
null
null
Low cancer specificity
Detected in all
null
null
Low region specificity
Detected in all
null
null
Low immune cell specificity
Detected in all
null
null
Low lineage specificity
Detected in all
null
null
Low cancer specificity
Detected in all
null
null
Spleen - Fibroblast_1
Low region specificity
Detected in all
null
null
Low region specificity
Detected in all
null
null
HPA012072, CAB022049
Enhanced
null
Supported
Plasma membrane,Focal adhesion sites,Cytosol
null
null
null
null
null
14,000,000
Cluster 38: Monocytes & Neutrophils - Degranulation
Cluster 25: Small intestine - Absorption
Cluster 38: Sub-cortical - Mixed function
Cluster 27: Breast cancer - Unknown function
Cluster 36: Late spermatids - Unknown function
35
Plasma membrane, Cytosol
Focal adhesion sites
CAB022049: , HPA012072: AB_1852714
unprognostic (8.07e-2)
unprognostic (3.35e-1)
unprognostic (5.77e-2)
unprognostic (9.20e-4)
unprognostic (3.18e-1)
unprognostic (1.48e-1)
unprognostic (2.52e-1)
unprognostic (8.20e-2)
unprognostic (1.49e-1)
unprognostic (4.68e-2)
unprognostic (5.01e-5)
unprognostic (9.04e-2)
unprognostic (3.62e-1)
unprognostic (8.54e-4)
unprognostic (9.46e-3)
unprognostic (2.53e-4)
unprognostic (9.54e-3)
unprognostic (8.17e-3)
unprognostic (2.25e-1)
unprognostic (2.63e-2)
unprognostic (1.46e-1)
unprognostic (4.16e-2)
unprognostic (1.19e-1)
unprognostic (1.41e-1)
unprognostic (6.40e-2)
unprognostic (1.49e-1)
unprognostic (6.83e-2)
unprognostic (1.60e-2)
unprognostic (2.68e-1)
unprognostic (3.98e-2)
unprognostic (2.26e-1)
SNX11
null
ENSG00000002919
Sorting nexin 11
Q9Y5W9
17
48103357-48123601
Predicted intracellular proteins
Protein transport, Transport
null
null
Evidence at protein level
Evidence at protein level
Evidence at protein level
Evidence at protein level
Low tissue specificity
Detected in all
null
null
Cell type enhanced
Detected in all
null
Oocytes: 36.0
Low cell type specificity
Detected in all
null
null
Low cancer specificity
Detected in all
null
null
Low region specificity
Detected in all
null
null
Low immune cell specificity
Detected in all
null
null
Low lineage specificity
Detected in all
null
null
Low cancer specificity
Detected in all
null
null
null
Low region specificity
Detected in all
null
null
Low region specificity
Detected in all
null
null
HPA044787, HPA054660
Approved
null
Approved
Endoplasmic reticulum,Vesicles
null
null
null
null
null
null
Cluster 28: Neutrophils - Unknown function
Cluster 70: Lymphoid tissue - Immune response
Cluster 13: Oligodendrocytes - Mixed function
Cluster 55: Lymphoma - Immune response
Cluster 14: Langerhans cells - Innate immune response
10
Endoplasmic reticulum
Vesicles
HPA044787: AB_10795988, HPA054660: AB_2682560
unprognostic (8.83e-2)
unprognostic (7.86e-3)
unprognostic (2.35e-1)
unprognostic (9.77e-2)
unprognostic (4.46e-2)
unprognostic (1.01e-2)
unprognostic (9.13e-2)
unprognostic (6.92e-3)
unprognostic (9.92e-2)
unprognostic (7.29e-2)
unprognostic (3.06e-5)
unprognostic (4.02e-2)
unprognostic (5.99e-4)
unprognostic (2.27e-4)
unprognostic (2.62e-3)
unprognostic (3.47e-1)
unprognostic (1.67e-1)
unprognostic (4.76e-2)
unprognostic (2.08e-1)
unprognostic (5.54e-2)
unprognostic (6.57e-3)
unprognostic (1.31e-1)
unprognostic (3.67e-2)
unprognostic (2.52e-1)
unprognostic (1.46e-2)
unprognostic (1.73e-1)
unprognostic (2.08e-1)
unprognostic (2.21e-1)
unprognostic (1.63e-1)
unprognostic (1.37e-1)
unprognostic (1.13e-1)
End of preview. Expand in Data Studio

Human Protein Atlas v25: subcellular localization and full annotation tables

A verbatim mirror of three Human Protein Atlas (HPA) release files, packaged together with an explicit provenance and schema description. Nothing here is derived, filtered, or recomputed: the bytes are exactly what the upstream endpoints served.

The point of this repository is reproducibility. HPA serves only the current release at a stable URL, so a file downloaded six months from now will silently differ from the one used in a past experiment. Each file below is pinned with a SHA-256 and a retrieval date.

What HPA is

The Human Protein Atlas is a Swedish research program that maps the human proteome using antibody-based imaging, mass spectrometry, and transcriptomics. The subcellular section (the Cell Atlas) assigns proteins to organelles and subcellular structures by immunofluorescence (IF/ICC) in human cell lines, with a four-tier reliability grading. The measured entity is protein, but records are keyed by gene (ENSG), because HPA entries are gene-centric.

Files

File Size Rows x Cols HPA version Retrieved SHA-256
subcellular_location.tsv 2,046,017 B 13,603 x 14 v25 2026-07-05 19ee031772375318e75556e43a5103cd8d919f7757094ef3fd134fba134fc095
proteinatlas.xml.gz 729,899,935 B 20,162 entries v25 (declared in file) 2026-04-21 a8d12feab9d1c9846787fdd3f5efbe843d4247a898227830ff870ac18287f8ca
unversioned_mirror/proteinatlas.tsv 36,611,106 B 20,162 x 107 undetermined, pre-v25 2026-04-04 5f629a170520b747d12e2602471e0bbc2ee6a5c4968353f00143ffe26cec154a

Upstream sources:

  • subcellular_location.tsv from https://www.proteinatlas.org/download/tsv/subcellular_location.tsv.zip (unzipped, byte-identical to the archive member). Upstream Last-Modified was 2025-11-06, consistent with the v25.0 data drop (v25.0 released 2025-11-11).
  • proteinatlas.xml.gz from https://www.proteinatlas.org/download/proteinatlas.xml.gz. The file declares its own version: schemaLocation="https://v25.proteinatlas.org/download/proteinatlas.xsd", schemaVersion="3.0", and every <entry version="25">. Identifiers are Ensembl 109 on GRCh38.p13, GENCODE 43. gzip -t passes.
  • unversioned_mirror/proteinatlas.tsv was not obtained from HPA directly. It came from a third-party data-lake mirror (the Biomni data lake). See the version warning below.

subcellular_location.tsv schema

13,603 genes, 14 tab-separated columns. This is the Cell Atlas summary table: one row per gene, aggregating IF observations across the cell lines that gene was stained in.

# Column Non-null Description
1 Gene 100% Ensembl gene ID (ENSG). 13,603 unique. The reliable join key.
2 Gene name 100% HGNC symbol. Only 13,597 unique, see caveats.
3 Reliability 100% Gene-level summary grade: Approved 6,999 / Supported 4,582 / Enhanced 1,230 / Uncertain 792
4 Main location 100% (13,602) Primary localization, semicolon-separated, multi-label
5 Additional location 46.5% Secondary localization, semicolon-separated
6 Extracellular location 5.4% Single value Predicted to be secreted for 740 genes. A prediction, not a measurement.
7 Enhanced 9.6% Locations whose evidence reached the Enhanced tier
8 Supported 38.7% Locations at the Supported tier
9 Approved 58.8% Locations at the Approved tier
10 Uncertain 17.9% Locations at the Uncertain tier
11 Single-cell variation intensity 26.8% Compartments showing cell-to-cell intensity heterogeneity (3,650 genes)
12 Single-cell variation spatial 1.4% Compartments showing spatial heterogeneity (186 genes)
13 Cell cycle dependency 3.5% Cell-cycle-dependent structures (479 genes), e.g. Cytokinetic bridge, Mitotic spindle, Mitotic chromosome
14 GO id 100% Location terms with GO accessions, e.g. Cytosol (GO:0005829)

How columns 7-10 relate to columns 4-5

These four columns are not a repeat of the reliability grade. They re-partition the same location labels by evidence strength. Verified on this file:

  • For all 13,603 rows, Enhanced U Supported U Approved U Uncertain equals Main location U Additional location exactly. Zero exceptions.
  • 3,099 genes carry locations spanning more than one evidence tier (2 tiers: 2,806; 3 tiers: 292; 4 tiers: 1). Reliability reports only that gene's best tier.

Practical consequence: to drop low-confidence localizations, remove the terms listed in the Uncertain column, not the rows where Reliability == "Uncertain". The Uncertain column is non-null for 2,430 genes but only 786 of those have Reliability == "Uncertain", so row-level filtering leaves uncertain labels on 1,644 genes.

Multi-label structure

Main location count per gene: 1 location for 10,035 genes, 2 for 3,065, 3 for 407, 4 for 79, 5 for 10, 6 for 5, 7 for 1, and 1 gene with none. Additional location is empty for 7,277 genes.

Location vocabulary

49 distinct terms across Main location and Additional location, heavily skewed:

Nucleoplasm 6283, Cytosol 5267, Vesicles 2488, Plasma membrane 2263, Golgi apparatus 1279,
Mitochondria 1132, Nucleoli 1116, Nuclear bodies 626, Endoplasmic reticulum 576,
Centrosome 513, Nuclear speckles 507, Primary cilium 467, Basal body 451,
Principal piece 371, Microtubules 356, Mid piece 352, Cell Junctions 331,
Nucleoli fibrillar center 325, Nuclear membrane 295, Actin filaments 253,
Cytokinetic bridge 245, Centriolar satellite 228, End piece 195, Mitotic spindle 161,
Nucleoli rim 153, Focal adhesion sites 148, Intermediate filaments 147,
Primary cilium tip 130, Flagellar centriole 116, Acrosome 112,
Primary cilium transition zone 96, Connecting piece 92, Equatorial segment 82,
Mitotic chromosome 79, Cytoplasmic bodies 74, Perinuclear theca 70, Calyx 70,
Midbody 56, Annulus 50, Lipid droplets 40, Midbody ring 25, Peroxisomes 24,
Lysosomes 20, Rods & Rings 19, Aggresome 19, Endosomes 16, Kinetochore 8,
Microtubule ends 7, Cleavage furrow 2

Two terms (Nucleoplasm, Cytosol) account for a large share of all annotations. Any analysis that treats compartment sharing as a uniform feature will be dominated by these two.

proteinatlas.xml.gz

The complete HPA v25 release in XML, 20,162 gene entries, roughly 700 MB compressed. This is the superset: everything in the TSV tables is derivable from it, plus data that has no TSV equivalent. Per-entry sections include identifier, name, synonym, proteinClasses, proteinEvidence, predictedLocation, antibody, tissueExpression, cellExpression, cellTypeExpression, cancerExpression, rnaExpression, and proteinstructure.

The antibody blocks are the reason to use the XML rather than the TSV. They carry per-antibody, per-cell-line IF results, including the individual imageUrl entries pointing at the raw immunofluorescence JPGs on images.proteinatlas.org. The summary TSV collapses all of that to one row per gene.

Stream it, do not load it. xml.etree.ElementTree.iterparse over gzip.open works fine and keeps memory flat.

unversioned_mirror/proteinatlas.tsv and its version warning

20,162 genes x 107 columns: the wide per-gene annotation table covering protein class, tissue and single-cell RNA specificity, blood and brain expression, antibody reliability, subcellular location, secretome, expression clusters, and TCGA prognostics.

This file is not from a pinned HPA release and its version could not be determined. It was mirrored from a third-party data lake, not from proteinatlas.org. It predates the v25 files above: its cancer column is RNA cancer specific FPKM, whereas v25 uses RNA cancer specific pTPM. Its subcellular columns also disagree with subcellular_location.tsv: Subcellular location and Subcellular main location are non-null for 13,534 and 13,533 genes, against 13,603 and 13,602 in the v25 table.

It is included because it is a convenient wide-format annotation table, and because leaving it out of a mirror while it circulates elsewhere unlabeled is worse than shipping it with the caveat attached. Do not cite it as a specific HPA release. If you need the wide table at a known version, download proteinatlas.tsv fresh from HPA and record the release number.

Caveats before you use this

  1. Cell-line context. HPA IF localization is measured mostly in U2OS, A-431, and U-251MG. The summary table is a cross-cell-line consensus, not a context-specific label. It does not describe localization in your cell line of interest.
  2. Antibody-dependent. Localization comes from antibody staining, so it inherits antibody specificity limits. The reliability tiers exist for this reason and should be used.
  3. Duplicate symbols. Gene name has 6 symbols appearing twice, each mapping to two distinct ENSGs: NPIPA9, POLR2J3, MATR3, HERC3, PRODH, PINX1. Keying by symbol silently drops or merges records. Key by ENSG.
  4. Extracellular location is a prediction, not an observation, and should not be pooled with the measured location columns.
  5. Gene-level keying. Records are per gene, so isoform-resolved or proteoform-resolved localization is not available here. Antibody epitopes usually span regions shared by isoforms, making each label an isoform mixture.
  6. Not a quantitative readout. These are categorical assignments with a reliability grade, not abundances or fractional distributions across compartments.

Not included

The raw immunofluorescence images (roughly 92,000 JPGs, about 28 GB) are not mirrored here. Their URLs are inside proteinatlas.xml.gz under the antibody blocks and can be fetched directly from images.proteinatlas.org.

License and citation

HPA data is released under CC BY 4.0, which permits redistribution with attribution. This mirror carries the same license. HPA notes that some integrated third-party datasets within the atlas may carry their own terms, so check before reusing a specific subset commercially.

Required attribution, per HPA: cite a primary publication and reference the Human Protein Atlas with a versioned URL, https://v25.proteinatlas.org.

Cell Atlas primary reference:

Thul PJ, et al. A subcellular map of the human proteome. Science. 2017;356(6340):eaal3321.

Loading

import pandas as pd

loc = pd.read_csv("subcellular_location.tsv", sep="\t", dtype=str)

# correct low-confidence filtering: drop terms, not rows
def clean_locations(row):
    keep = set()
    for col in ("Main location", "Additional location"):
        v = row[col]
        if isinstance(v, str):
            keep |= {x.strip() for x in v.split(";")}
    unc = row["Uncertain"]
    if isinstance(unc, str):
        keep -= {x.strip() for x in unc.split(";")}
    return keep

loc["locations"] = loc.apply(clean_locations, axis=1)
# stream the XML instead of loading it
import gzip, xml.etree.ElementTree as ET

with gzip.open("proteinatlas.xml.gz", "rb") as fh:
    for _, elem in ET.iterparse(fh, events=("end",)):
        if elem.tag == "entry":
            ...
            elem.clear()
Downloads last month
31